Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe United States | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Latin America | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Taiwan | zh
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Global | en
  • Novartis Foundation | en
  • Sandoz | en
  • Egypt | en
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe United States

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latin America | es
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Novartis in the US
        • Company at a Glance
        • By the Numbers
        • Diversity and Inclusion
        • Pay Transparency-EPIC
        • Our Code of Ethics
      • Strategy
      • Diversity and Inclusion
        • Ensuring Equity
        • The Spirit of Inclusivity
        • Toward a better society
        • Parental Leave
        • Standing for Racial Equity and Justice as One Novartis
        • Novartis US EEO / D&I Report 2021
        • Supplier Diversity
      • People and Culture
      • Products
      • Country Leadership Team
      • External Funding
      • Contact Us
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Patient Assistance
      • Diseases
      • Participating in Clinical Trials
      • Patient Perspectives
      • Adverse Event Reporting
      • The STEP Program
        • Sickle Cell Disease (SCD)
        • Program Overview
        • Multiple Sclerosis (MS)
        • Cancer
        • Application for Funding to Help Address Health Disparities
        • Health Disparities
      Patients and Caregivers
    • Healthcare Professionals
      • Novartis Pipeline
      • Novartis Clinical Trials
      • Adverse Event Reporting
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
        • PhRMA Code on Interactions with Healthcare Professionals
        • Business Principles
      • Ethics, Risk and Compliance
        • Compliance Program
        • State Laws
        • Corporate Integrity Agreement
        • Payments to HCPs & HCOs
        • Enhanced Verification Request
      • Corporate Responsibility
        • Population Health
        • Novartis in Society US Reports
        • Novartis US Foundation
        • Environmental Sustainability
        • People and Communities
      • Beacon of Hope
        • Beacon of Hope: Measurable solutions for health equity
      ESG
    • News
      • News Archive
      • Statements
      • Stories
      • Contacts
      News
    • Careers
      • Career Search
      • Meet the Teams
      • Career Programs
      • Personal Growth
      • Early Talent
      • How We Work
      • Employee Benefits
      • Diversity and Inclusion
      • Awards & Recognition
      Careers
    • Coronavirus
      Coronavirus
    Home
Header
Co-workers having a meeting

News

News and more from the frontiers of medicine

Previous Next
Team meeting

News Archive

Read in-depth news about how Novartis is addressing healthcare needs through recent headlines.

Man speaking into a hands-free headset

Statements

Find information and the latest updates and background information on recent events related to a few of our key products.

Woman working in an office cubicle

Media contacts

Find contacts at Novartis for media and journalist inquiries from the general and individual contacts.

lung-cancer-hero-image

Stories

Our research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.

28 Jul 2022 11:00:03 [email protected]

In our latest edition of “Let’s Talk About the C Word,” award-winning entrepreneur, author, and mentor @LeannePero showcases the humanity of people’s experiences with cancer. #CWordSeries

27 Jul 2022 11:00:02 [email protected]

Creating a paradigm shift in health equity requires collective effort. We look forward to participating in @PhRMA’s initiative. Together with our #HBCUBeaconofHope collaboration we can help increase trust among diverse communities and accelerate equitable access to trials. https://t.co/mtLx6pCRA2

Previous Next

Novartis United States

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Statements
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis US Websites
  • Oncology HCP Resources
  • Gene Therapy Network
  • Medical Information
  • Sandoz
  • Global Site
Footer Bottom
© 2022 Novartis Pharmaceuticals Corporation
  • Terms of Use
  • Privacy Policy
  • Contacts
  • About Cookies
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for US Residents Only